ESC Premium Access

A novel autologous heart valve with growth potential

Congress Presentation

About the speaker

Professor Yoshiaki Takewa

Asahikawa Medical University, Asahikawa (Japan)
0 follower

6 more presentations in this session

Long-term outcome of mitral valve repair versus replacement in a large series of patients with infective endocarditis

Speaker: Associate Professor E. Ruttmann-Ulmer (Innsbruck, AT)

Thumbnail

Comparison of contemporary risk scores for predicting mortality and morbidity after mitral valve surgery

Speaker: Doctor T. Wang (Cleveland, US)

Thumbnail

Performance of existing clinical prediction models for predicting mortality after transcatheter aortic valve implantation

Speaker: Mr G. Martin (Manchester, GB)

Thumbnail

Metabolic syndrome affects valve-related adverse events after biological heart valve replacement

Speaker: Doctor E. Angeloni (Rome, IT)

Thumbnail

Can TAVI patients receive aspirin monotherapy as patients after surgical aortic bioprosthesis implantation? Data from the Polish Registry POL-TAVI.

Speaker: Doctor K. Czerwinska-Jelonkiewicz (London, GB)

Thumbnail

Access the full session

Valve repair and assist devices

Speakers: Professor Y. Takewa, Associate Professor E. Ruttmann-Ulmer, Doctor T. Wang, Mr G. Martin, Doctor E. Angeloni...
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb